Shareprice
19 Mar 2025

Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

2025

12 March, 2025 Notice of Annual General Meeting in FluoGuide A/S News Corporate Information General meeting Notice English Regulatory Listing Regulation IR
The board of directors hereby convenes the Annual General Meeting of FluoGuide A/S, company registration (CVR) no. 39 29 64 38 (the...
27 February, 2025 FluoGuide A/S publishes year-end and annual report for the fiscal year 2024 News English Regulatory Listing Regulation Report Annual IR
Copenhagen, Denmark, 27 February 2025 - FluoGuide A/S (“FluoGuide” or the “Company”) hereby publishes its annual...
27 February, 2025 FluoGuide A/S publishes interim report for the period January – December 2024 News English Regulatory Listing Regulation Report Interim Yearend IR
Copenhagen, Denmark, 27 February 2025 – Fluoguide A/S (“FluoGuide” or the “Company”) today releases its...
15 January, 2025 FluoGuide A/S receives approval for phase II trial in head and neck cancer News Corporate Information Other Corporate Information English IR
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing in...

2024

27 November, 2024 FluoGuide A/S publishes interim report for the period January – September 2024 News English Regulatory Listing Regulation Report Interim Q3 IR
Copenhagen, Denmark, 27 November 2024 – Fluoguide A/S (“FluoGuide” or the “Company”) today releases its...
Copenhagen, Denmark, 19 November 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce...
12 November, 2024 FluoGuide A/S issue warrants to board member, CMO and CFO News Corporate Action Other English Regulatory Listing Regulation IR
Copenhagen, Denmark, 12 November 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) announces issuing...
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biothech company specializing in...
7 October, 2024 FluoGuide A/S submits Clinical Trial Application for phase II trial in head and neck cancer News Corporate Information Other Corporate Information English IR
Copenhagen, Denmark - FluoGuide A/S (“FluoGuide” or the “Company”), a biothech company specializing in precision...

Calendar &
upcoming reports


29 August 2024

Q2 report 2024


27 November 2024

Q3 report 2024


27 February 2025

Annual report 2024

Show all posts